The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
CDK inhibitors: positive and negative regulators of G1-phase progression
Open accessAbstract
Mitogen-dependent progression through the first gap phase (G1) and initiation of DNA synthesis (S phase) during the mammalian cell division cycle are cooperatively regulated by several classes of cyclin-dependent kinases (CDKs) whose activities are in turn constrained by CDK inhibitors (CKIs). CKIs that govern these events have been assigned to one of two families based on their structures and CDK targets. The first class includes the INK4 proteins (inhibitors of CDK4), so named for their ability to specifically inhibit the catalytic subunits of CDK4 and CDK6. Four such proteins [p16 (Serrano et al. 1993), p15 (Hannon and Beach 1994), p18 (Guan et al. 1994; Hirai et al. 1995), and p19 (Chan et al. 1995; Hirai et al. 1995)] are composed of multiple ankyrin repeats and bind only to CDK4 and CDK6 but not to other CDKs or to D-type cyclins. The INK4 proteins can be contrasted with more broadly acting inhibitors of the Cip/Kip family whose actions affect the activities of cyclin D-, E-, and A-dependent kinases. The latter class includes p21 (Gu et al. 1993; Harper et al. 1993; El-Deiry et al. 1993; Xiong et al. 1993a; Dulic et al. 1994; Noda et al. 1994), p27 (Polyak et al. 1994a,b; Toyoshima and Hunter 1994), and p57 (Lee et al. 1995; Matsuoka et al. 1995), all of which contain characteristic motifs within their amino-terminal moieties that enable them to bind both to cyclin and CDK subunits (Chen et al. 1995, 1996; Nakanishi et al. 1995; Warbrick et al. 1995; Lin et al. 1996; Russo et al. 1996). Based largely on in vitro experiments and in vivo overexpression studies, CKIs of the Cip/Kip family were initially thought to interfere with the activities of cyclin D-, E-, and A-dependent kinases. More recent work has altered this view and revealed that although the Cip/Kip proteins are potent inhibitors of cyclin Eand A-dependent CDK2, they act as positive regulators of cyclin Ddependent kinases. This challenges previous assumptions about how the G1/S transition of the mammalian cell cycle is governed, helps explain some enigmatic features of cell cycle control that also involve the functions of the retinoblastoma protein (Rb) and the INK4 proteins, and changes our thinking about how either p16 loss or overexpression of cyclin D-dependent kinases contribute to cancer. Here we focus on the biochemical interactions that occur between CKIs and cyclin Dand E-dependent kinases in cultured mammalian cells, emphasizing the manner by which different positive and negative regulators of the cell division cycle cooperate to govern the G1-to-S transition. To gain a more comprehensive understanding of the biology of CDK inhibitors, readers are encouraged to refer to a rapidly emerging but already extensive literature (for review, see Elledge and Harper 1994; Sherr and Roberts 1995; Chellappan et al. 1998; Hengst and Reed 1998a; Kiyokawa and Koff 1998; Nakayama 1998; Ruas and Peters 1998).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, we found that incubation of AHPs with IL-1β induces a dramatic decline in levels of cyclin D1, a cell cycle regulatory protein that controls specific cyclin-dependent kinases such as cdk4 (31).”
From IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress (2008) · cites this paper as [31]
In the citing paper
“Due to the critical regulatory role of these cell cycle factors, senescence signaling typically acts by decreasing cyclin–CDK activity or increasing CDK inhibitor levels.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [34]
In the citing paper
“CDK4/6 activity bridges numerous extracellular signaling pathways to the cell cycle (Sherr and Roberts, 1999).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Sherr and Roberts, 1999
In the citing paper
“Naturally occurring pan-CDK inhibitors, including p21Cip1 and p27Kip1, facilitate cyclin D-CDK assembly and the nuclear import of the resulting complexes without inhibiting CDK4/6 kinase activity (41, 48-51).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [41]
In the citing paper
“In many cell types, transcription of CCND1 and cyclin D1 assembly with CDK4 each depend on activation of a RAS-dependent kinase cascade that relies on the sequential activities of RAF1, MEK1 and MEK2, and ERKs (39-42).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“…accumulates progressively as cells age, possibly being induced by a senescence timer (Alcorta et al. 1996; Hara et al. 1996; Palmero et al. 1997; Serrano et al. 1997; Zindy et al. 1997a), whereas p18INK4c and p19INK4d are focally expressed during fetal development and may have roles in…”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
Self-citationThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,208
Flagged first, then by citations
Research works printed but not linked: 1
- Medema, R.H., R.E. Herrera, F. Lam, and R.A. Weinberg. 1995. Growth suppression by p16 ink4 requires functional retino- blastoma protein. Proc. Natl. Acad. Sci. 92: 6289-6293.
Cited by
Sorted by citations
Items 101–150 of 150
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Molecular Processes that Drive Cigarette Smoke–Induced Epithelial Cell Fate of the Lung
Nyunoya, T., Mebratu, Y., Contreras, A., Delgado, M., Chand, H. S., & Tesfaigzi, Y. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0348tr · Cited by 110
Du, Z., Treiber, D., McCarter, J. D., Fomina‐Yadlin, D., Saleem, R. A., McCoy, R. E., Zhang, Y., Tharmalingam, T., Leith, M., Follstad, B. D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25332 · Cited by 113
Pucilowska, J., Puzerey, P. A., Karlo, J. C., Galan, R. F., & Landreth, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1107-12.2012 · Cited by 99
Pechnick, R. N., Zonis, S., Wawrowsky, K., Pourmorady, J., & Chesnokova, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711030105 · Cited by 103
Huang, X., Di Liberto, M., Jayabalan, D., Liang, J., Ely, S., Bretz, J., Shaffer, A. L., Louie, T., Chen, I., Randolph, S., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415984 · Cited by 102
Smurf2 up-regulation activates telomere-dependent senescence
Zhang, H., & Cohen, S. N. (2004) · Genes & Development · doi:10.1101/gad.1253004 · Cited by 100
Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer
Lim, S., Yoo, B. K., Kim, H.-S., Gilmore, H. L., Lee, Y., Lee, H.-P., Kim, S.-J., Letterio, J., & Lee, H.-G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-928 · Cited by 100
Hsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinase
Diehl, J. A., Yang, W., Rimerman, R. A., Xiao, H., & Emili, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1764-1774.2003 · Cited by 97
Yamada, T., Hiraoka, Y., Ikehata, M., Kimbara, K., Avner, B. S., Das Gupta, T. K., & Chakrabarty, A. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400899101 · Cited by 98
Senescence as a general cellular response to stress: A mini-review
Fridlyanskaya, I., Alekseenko, L., & Nikolsky, N. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.09.021 · Cited by 97
Latella, L., Sacco, A., Pajalunga, D., Tiainen, M., Macera, D., D'Angelo, M., Felici, A., Sacchi, A., & Crescenzi, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5631-5643.2001 · Cited by 94
Matushansky, I., Radparvar, F., & Skoultchi, A. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250488697 · Cited by 84
Tabe, Y., Sebasigari, D., Jin, L., Rudelius, M., Davies-Hill, T., Miyake, K., Miida, T., Pittaluga, S., & Raffeld, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0399 · Cited by 83
Smad3 phosphorylation by cyclin-dependent kinases
LIU, F. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.010 · Cited by 71
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Laminin α5 influences the architecture of the mouse small intestine mucosa
Mahoney, Z. X., Stappenbeck, T. S., & Miner, J. H. (2008) · Journal of Cell Science · doi:10.1242/jcs.025528 · Cited by 74
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Ohtani, N., Imamura, Y., Yamakoshi, K., Hirota, F., Nakayama, R., Kubo, Y., Ishimaru, N., Takahashi, A., Hirao, A., Shimizu, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706949104 · Cited by 73
Chiron, D., Martin, P., Di Liberto, M., Huang, X., Ely, S., Lannutti, B. J., Leonard, J. P., Mason, C. E., & Chen-Kiang, S. (2013) · Cell Cycle · doi:10.4161/cc.24928 · Cited by 71
Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72
Ungermannova, D., Lee, J., Zhang, G., Dallmann, H. G., McHenry, C. S., & Liu, X. (2013) · SLAS Discovery · doi:10.1177/1087057113485789 · Cited by 70
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma
Sachdeva, U. M., & O’Brien, J. M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57114 · Cited by 67
Kennedy, A. L., McBryan, T., Enders, G. H., Johnson, F. B., Zhang, R., & Adams, P. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-16 · Cited by 61
Butt, A. J., Caldon, C. E., McNeil, C. M., Swarbrick, A., Musgrove, E. A., & Sutherland, R. L. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-78818-0_12 · Cited by 59
Carbonneau, C. L., Despars, G., Rojas-Sutterlin, S., Fortin, A., Le, O., Hoang, T., & Beauséjour, C. M. (2012) · Blood · doi:10.1182/blood-2011-06-361626 · Cited by 59
Cellular senescence: a double‐edged sword in the fight against cancer
Ohtani, N., Takahashi, A., Mann, D. J., & Hara, E. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01493.x · Cited by 57
PPARγ ligand attenuates PDGF-induced mesangial cell proliferation: Role of MAP kinase
Ghosh, S. S., Gehr, T. W. B., Ghosh, S., Fakhry, I., Sica, D. A., Lyall, V., & Schoolwerth, A. C. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00054.x · Cited by 53
Lewis, J. L., Chinswangwatanakul, W., Zheng, B., Marley, S. B., Nguyen, D. X., Cross, N. C. P., Banerji, L., Glassford, J., Thomas, N. S. B., Goldman, J. M., et al. (2001) · Blood · doi:10.1182/blood.v97.9.2604 · Cited by 53
An update on the implications of cyclin D1 in melanomas
González‐Ruiz, L., González‐Moles, M. Á., González‐Ruiz, I., Ruiz‐Ávila, I., Ayén, Á., & Ramos‐García, P. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12874 · Cited by 49
Brumby, A., Secombe, J., Horsfield, J., Coombe, M., Amin, N., Coates, D., Saint, R., & Richardson, H. (2004) · Genetics · doi:10.1534/genetics.104.026617 · Cited by 49
Kang, H.-J., Seo, H.-A., Go, Y., Oh, C. J., Jeoung, N. H., Park, K.-G., & Lee, I.-K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061411 · Cited by 49
“The level of p21, a key regulator of cell cycle progression during G1 phase [25], increased in 3T3-L1 preadipocytes treated with DMF for 48 h, compared with cells incubated in the absence of DMF (Fig.”
BackgroundSicinska, E., Lee, Y.-M., Gits, J., Shigematsu, H., Yu, Q., Rebel, V. I., Geng, Y., Marshall, C. J., Akashi, K., Dorfman, D. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00800-06 · Cited by 45
Allan, G., Ouadid-Ahidouch, H., Sanchez-Fernandez, E. M., Risquez-Cuadro, R., Fernandez, J. M. G., Ortiz-Mellet, C., & Ahidouch, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076411 · Cited by 45
Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma
Ciznadija, D., Liu, Y., Pyonteck, S. M., Holland, E. C., & Koff, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1031 · Cited by 44
Cdk5 and the non-catalytic arrest of the neuronal cell cycle
Zhang, J., & Herrup, K. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7045 · Cited by 44
Ye, W., Mairet‐Coello, G., Pasoreck, E., & DiCicco‐Bloom, E. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20680 · Cited by 43
Dulic, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_2 · Cited by 42
Huang, Y., Yoon, M.-K., Otieno, S., Lelli, M., & Kriwacki, R. W. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.11.011 · Cited by 36
Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents
Pahl, P. M. B., & Horwitz, L. D. (2005) · Cancer Investigation · doi:10.1080/07357900500359976 · Cited by 40
Zhao, L., Li, Y. Y., Li, C. W., Chao, S. S., Liu, J., Nam, H. N., Dung, N. T. N., Shi, L., & Wang, D. Y. (2017) · Allergy · doi:10.1111/all.13074 · Cited by 37
Zhou, Y., Luo, K., Liang, L., Chen, M., & He, X. (2023) · Nature Methods · doi:10.1038/s41592-023-02017-4 · Cited by 34
Nutlin-3 Affects Expression and Function of Retinoblastoma Protein
Du, W., Wu, J., Walsh, E. M., Zhang, Y., Chen, C. Y., & Xiao, Z.-X. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046904 · Cited by 33
Tátrai, E., Bartal, A., Gacs, A., Paku, S., Kenessey, I., Garay, T., Hegedűs, B., Molnár, E., Cserepes, M. T., Hegedűs, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17806 · Cited by 33
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29
TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
Meyer, R. D., Zou, X., Ali, M., Ersoy, E., Bondzie, P. A., Lavaei, M., Alexandrov, I., Henderson, J., & Rahimi, N. (2018) · Oncotarget · doi:10.18632/oncotarget.23822 · Cited by 24
Stress-induced (Premature) senescence
Debacq-Chainiaux, F., Ben Ameur, R., Bauwens, E., Dumortier, E., Toutfaire, M., & Toussaint, O. (2016) · Healthy Ageing and Longevity · doi:10.1007/978-3-319-26239-0_13 · Cited by 31
Marazita, M. C., Ogara, M. F., Sonzogni, S. V., Martí, M., Dusetti, N. J., Pignataro, O. P., & Cánepa, E. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035638 · Cited by 22
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Cyclin E and cyclin A are likely targets of Src for PDGF‐induced DNA synthesis in fibroblasts
Furstoss, O., Manes, G., & Roche, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03120-4 · Cited by 13
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- ORCID
- Sherr, C. J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-06-15
- Volume
- 13
- Issue
- 12
- Pages
- 1501-1512
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2121619780
- Cited by
- 6,115
- References
- 151
- Citations by year
- 2026: 71 · 2025: 97 · 2024: 94 · 2023: 122 · 2022: 137 · 2021: 148 · 2020: 149 · 2019: 142 · 2018: 146 · 2017: 160 · 2016: 154 · 2015: 208 · 2014: 207 · 2013: 234 · 2012: 255
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- cyclin-dependent kinase inhibitors, cyclin-dependent kinases, G1 phase progression, cell cycle regulation, p16, p21, p27, p57, CDK4, CDK6, cyclin D, cyclin E, cyclin A, ankyrin repeats, cell cycle checkpoint control, tumor suppressor
- MeSH terms
- Animals, Carrier Proteins, Catalysis, Cell Cycle, Enzyme Inhibitors, Humans, Microtubule-Associated Proteins, Neoplasms, G1 Phase, Cyclins, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Holoenzymes, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase Inhibitor p27, Cyclin-Dependent Kinase Inhibitor p19, Cyclin D
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
